§ 40.199 What problems always cause a drug test to be cancelled?
Wording first on file in the 2001 annual edition, superseded November 13, 2017.
(a) As the MRO, when the laboratory discovers a “fatal flaw” during its processing of incoming specimens (see § 40.83), the laboratory will report to you that the specimen has been “Rejected for Testing” (with the reason stated). You must always cancel such a test.
(b) The following are “fatal flaws”:
(1) There is no printed collector's name and no collector's signature;
(2) The specimen ID numbers on the specimen bottle and the CCF do not match;
(3) The specimen bottle seal is broken or shows evidence of tampering (and a split specimen cannot be redesignated, see § 40.83(g)); and
(4) Because of leakage or other causes, there is an insufficient amount of urine in the primary specimen bottle for analysis and the specimens cannot be redesignated (see § 40.83(g)).
(c) You must report the result as provided in § 40.161 .
Amendment history
5 distinct wordings on file since Oct. 1, 2001- [65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017; 88 FR 27648, May 2, 2023]
- [65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017]
- [65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017]
A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.